C21 Investments Inc (TSE:CXXI)
:CXXI
Top Page
C21 Investments
(CXXI)
Select Model
Select Model
Rating:52Neutral
Price Target:
C$0.38
▼(-13.86% Downside)
Action:ReiteratedDate:03/28/26
The score is driven primarily by improving fundamentals (sharp revenue rebound and better operating margins) but held back by continued net losses and uneven cash-flow durability. Technicals are weak (below major moving averages with negative MACD), and valuation support is limited given losses and no dividend yield.
Positive Factors
Revenue rebound
A 70.5% TTM revenue rebound signals durable demand recovery and expanding market penetration across retail and wholesale channels. Strong top-line momentum supports operating leverage, scale benefits in cultivation/retail, and provides a platform for sustained margin improvement if maintained.
Negative Factors
Persistent net losses
Despite revenue and operating gains, a TTM net margin around -9% shows the company still posts bottom-line losses. Persistent losses can necessitate external funding, dilute shareholders if equity is issued, and delay positive return metrics that attract long-term investors.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue rebound
A 70.5% TTM revenue rebound signals durable demand recovery and expanding market penetration across retail and wholesale channels. Strong top-line momentum supports operating leverage, scale benefits in cultivation/retail, and provides a platform for sustained margin improvement if maintained.
Read all positive factors
C21 Investments (CXXI) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$81.77M
Dividend YieldN/A
Average Volume (3M)41.58K
Price to Earnings (P/E)―
Beta (1Y)1.43
Revenue Growth23.29%
EPS Growth33.65%
CountryCA
Employees114
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding118,040,070
10 Day Avg. Volume50,757
30 Day Avg. Volume41,578
Financial Highlights & Ratios
PEG Ratio1.66
Price to Book (P/B)1.70
Price to Sales (P/S)1.37
P/FCF Ratio34.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
C21 Investments Business Overview & Revenue Model
Company Description
C21 Investments (CXXI) is a diversified investment company focused on the cannabis sector, particularly in the cultivation, processing, and retail of cannabis products. The company operates in various states where cannabis is legal, providing a wi...
How the Company Makes Money
C21 Investments makes money primarily by selling cannabis and cannabis-derived products through two main channels: (1) retail sales at company-owned dispensaries, where revenue is generated from direct-to-consumer transactions and the company capt...
C21 Investments Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
63
Positive
Cash Flow
52
Neutral
| Breakdown | Dec 2025 | Mar 2025 | Apr 2023 | Apr 2022 | Apr 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 33.27M | 30.12M | 28.29M | 28.89M | 33.47M |
| Gross Profit | 13.99M | 12.56M | 11.15M | 13.40M | 18.05M |
| EBITDA | 4.57M | 2.90M | 2.63M | 6.98M | 5.79M |
| Net Income | -3.44M | -3.97M | -3.31M | 293.21K | -7.83M |
Balance Sheet | |||||
| Total Assets | 54.89M | 57.00M | 54.53M | 58.31M | 68.81M |
| Cash, Cash Equivalents and Short-Term Investments | 2.42M | 2.63M | 2.41M | 1.89M | 6.24M |
| Total Debt | 10.95M | 13.15M | 10.72M | 12.14M | 27.30M |
| Total Liabilities | 28.05M | 28.32M | 23.48M | 24.00M | 43.47M |
| Stockholders Equity | 26.84M | 28.68M | 31.05M | 34.32M | 25.34M |
Cash Flow | |||||
| Free Cash Flow | 1.31M | -2.63M | 5.46M | 5.46M | 9.70M |
| Operating Cash Flow | 1.44M | 1.19M | 5.90M | 5.90M | 9.92M |
| Investing Cash Flow | 223.14K | -3.12M | -390.93K | -390.93K | -1.10M |
| Financing Cash Flow | -1.78M | 1.27M | -6.68M | -6.68M | -5.70M |
C21 Investments Technical Analysis
Negative
0.44
Price Trends
0.40
Negative
0.43
Negative
0.43
Negative
Market Momentum
>-0.01
Negative
47.69
Neutral
71.60
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CXXI, the sentiment is Negative. The current price of 0.44 is above the 20-day moving average (MA) of 0.39, above the 50-day MA of 0.40, and above the 200-day MA of 0.43, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.69 is Neutral, neither overbought nor oversold. The STOCH value of 71.60 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CXXI.
C21 Investments Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | C$175.39M | 4.61 | 27.19% | ― | 27.38% | ― | |
54 Neutral | C$126.15M | -1.92 | -275.39% | ― | -4.23% | 37.33% | |
52 Neutral | C$81.77M | -18.63 | -12.42% | ― | 23.29% | 33.65% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | C$139.79M | -2.48 | 75.97% | ― | 3.17% | -24.07% | |
47 Neutral | C$70.56M | -1.02 | -80.81% | ― | 2.19% | -91.41% | |
46 Neutral | C$62.56M | -0.85 | 163.84% | ― | ― | ― |
* Healthcare Sector Average
TSE:CXXI
C21 Investments
0.38
0.16
70.45%
TSE:JUSH
Jushi Holdings
0.70
0.30
75.00%
TSE:XLY
Auxly Cannabis Group
0.13
0.05
66.67%
TSE:LEEF
Leef Brands
0.24
0.05
30.56%
TSE:CWEB
Charlotte's Web Holdings
0.79
0.66
507.69%
TSE:PLTH
Planet 13 Holdings
0.22
-0.13
-36.76%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.